Patent · US Active

Treatment of alzheimer'S disease (AD) with an aluminum salt

US10646565B2 · kind B2 · utility

1Cited by

1References

19Claims

0Family size

Assignee

AFFIRIS AG · AT

Inventors

Markus Mandler · Wien, AT
Achim Schneeberger · Fort Lauderdale, US
Frank Mattner · Wien, AT
Walter Schmidt · Wien, AT

Key dates

Filing date	Apr 29, 2015
Grant date	May 12, 2020
Priority date	—
Expiry date	Apr 29, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a method for the treatment of AD, wherein an immune stimulating pharmaceutical composition comprising an aluminium salt is administered to a patient having AD or having a risk to develop AD in an effective amount.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.